RxDoctor Payments Data

Magdiel Trinidad Hernandez, MD

Vascular Surgery · Colorado Springs, CONPI 1609025204

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (34.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Cook Incorporated at 38.5% of the total. Reporting peaked in 2021 at $5,479 and has fallen 86.5% since, to $737 in 2025.

$18,355in general payments, 2019–2025

Across 125 payments — averaging $146.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$7K
  • W. L. Gore & Associates, Inc.$4K
  • Silk Road Medical, Inc.$2K
  • Medtronic$2K
  • Cook Medical LLC$2K
  • Endologix LLC$1K
  • plus $1K from 8 others
$2,530in research payments, 2019–2025

Across 2 payments — averaging $1265.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$3K

What the payments were for

  • Consulting fees$3,59220%
  • Speaking & faculty fees$6,30434%
  • Travel & lodging$3,19617%
  • Food & beverage$5,26329%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,355 in reported general payments places this provider in the 75th percentile of 66 vascular surgery providers in Colorado.

See all vascular surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$174,873
Medicare patients
533
Services billed
1,086

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban14$12,844
ClopidogrelClopidogrel Bisulfate138$1,620
Cilostazol40$846

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →